Felix Oppel

10PUBLICATIONS
25CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 15, 2026
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibition.

|Oct 02, 2024
Mucosa-like differentiation of head and neck cancer cells is inducible and drives the epigenetic loss of cell malignancy.

Felix Oppel, Sarah Gendreizig, Laura Martinez-Ruiz

|Apr 03, 2023
Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.

Peter Goon, Odile Sauzet, Matthias Schuermann

|Sep 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.

Felix Oppel, Senyao Shao, Sarah Gendreizig

|Oct 20, 2021
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma.

Mark W Zimmerman, Adam D Durbin, Shuning He

|Mar 06, 2021
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.

Wenhao Yao, Xu Qian, Sebastian Ochsenreither

Pageof 2

Frequent Collaborators

5 joint publications

A Thomas Look

3 joint publications

Mark W Zimmerman

2 joint publications

Kenneth N Ross

2 joint publications

Shuning He